Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Enso Discoveries, LLC Launches its Domestic, Independently Owned, No Contract or Volume Commitment, Histopathology Laboratory for Veterinary Industry and CROs

Leave a comment


It is a continued commitment of Enso Discoveries to hire the best team of experts, pathologists and laboratory personnel to help provide priority lab services at non-priority lab prices.

“Our pathology network has extensive capacity to perform histologic processing and histopathologic evaluation of large quantities of tissue samples,” Director of Laboratory Services, Eric Pace said.


MANHATTAN, Kansas (PRWEB)

Enso Discoveries, LLC proudly announces the opening of its veterinary histopathology laboratory located centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an effort to offer partnering clients the ability to work with a highly motivated, independent, professional team that is focused on incredible quality, turnaround time and value, Enso Discoveries has built the infrastructure and assembled the scientific expertise to readily meet ever-evolving needs of contract research organization clients.

“We envisioned this laboratory over a year ago after successfully working internationally in this space. Six months ago we hired Eric Pace, an outstanding, talented and experienced Laboratory Manager with incredible passion, to build, hire, train and certify our laboratory. We feel that laboratory independence is a lost art with so much consolidation going on and we intend to build great relationships and add great value, to those who appreciate the independent, no contract or volume commitment model,” explains Patrick Farley, CEO of Enso Discoveries, LLC.

It is a continued commitment of Enso Discoveries to hire the best team of experts, pathologists and laboratory personnel to help provide priority lab services at non-priority lab prices. Under the watchful oversight of senior pathologists and experienced laboratory personnel, Enso Discoveries laboratory rigorously adheres to quality management standards applying technical and scientific expertise to every project, from routine procedures to highly specialized analyses.

Enso Discoveries Veterinary Histopathology Laboratory boasts:

  • Ability to process large case quantities without sacrificing quality

  • Quick turn-around time

  • Ability to provide dissection, gross examination, and organ size and weight measurement

  • Process samples for embedding and sectioning

  • Process samples for H&E, special stains, and Immunohistochemistry

  • Digitizing slides and delivery of digital image files

  • Perform quantitative image analysis and deliver a comprehensive report

“Our laboratory is a planned, high-production environment using the latest instruments such as the Leica Aperio AT2 imaging system that can process up to 400 slides an hour and dual Sakura tissue processors to ensure continued production. Our pathology network has extensive capacity to perform histologic processing and histopathologic evaluation of large quantities of tissue samples,” Director of Laboratory Services, Eric Pace said. “I am continually impressed with the budget I am supported with which allows me access to the latest in equipment, the best of technology, and the hiring of an amazing staff. Our commitment to quality in our work, and getting cases out in a timely manner, with the willingness to go the extra mile will be what helps veterinarians make sure they are offering proper treatment to each and every animal patient.”

Pace received his Bachelor’s of Animal Science with a minor in Natural and Applied Sciences in May of 2000. He brings 15 years of histopathology experience ranging in research, forensics, private sector, and large hospital laboratory. As an ASCP certified histology technician, he has helped train and teach many students from histology programs to become certified histology technicians. Pace is also a member of the Society of Quality Assurance, National Society of Histology and American Society of Clinical Pathology.

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the veterinarian, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your veterinarian or veterinary products distributor about Enso Discoveries, LLC products such as Rebound PRP™ and Rebound PRF® or learn more at http://www.ensodiscoveries.com.

Share article on social media or email:

Industry: Healthcare

Luma Health Providing 30-Day Free Access to Patient Broadcast Messaging to Healthcare Providers to Accelerate Patient Communications Around COVID-19

Leave a comment


News Image

We are dedicated to helping patients get access to care more quickly, and to working with medical heroes on the front lines to navigate through this global health crisis.


SAN FRANCISCO (PRWEB)

Luma Health https://www.lumahealth.io/, the leader in total patient engagement, today announced it has granted healthcare providers free 30-day access to its broadcast messaging product through April 30, to dramatically improve clinicians’ ability to get the right message and information out to patients to address fears, concerns, and false information as the world navigates COVID-19. In addition, for pre-screened patients or those with high-risk profiles for experiencing complications from the disease, Luma Health is offering a free 90-day trial for telehealth virtual visits to help reduce non-critical patient visits and unnecessary exposure for patients and care providers.

To sign up for the free broadcast patient communications, visit http://www.lumahealth.io/covid-19-patient-messaging.

The spread of the COVID-19 virus has created enormous challenges for clinics, hospitals, and healthcare systems across the United States, particularly in reaching patients with the most relevant information and access to care. A growing number of healthcare systems and clinics, including UCSF Health, UCSD Health, Salud Health Centers, Prima Care, Zufall Health Centers and many others are using Luma Health to reach their patients. In just this past week, Luma Health has helped over 80 clinics and systems reach their patient populations with COVID-19 related messages, potentially impacting and helping millions of patients across the U.S.

Key capabilities to Luma Health’s broadcast messaging solution include:

Uploading lists of patients directly from an organization’s electronic health record [EHR] system, taking less than a day for clinics and systems to implement.

Pre-built templates for COVID-19 patient messaging that can be customized to meet the needs of specific clinics, as well as an online questionnaire (https://bit.ly/covid-template) to help healthcare providers screen patients to determine if they require further testing.

Rapid and efficient targeting of select groups or entire populations with vital messaging related to their healthcare, such as informing high-risk patients about added precautions to help limit the spread of COVID-19.

“In the war on COVID-19, it is critically important that healthcare professionals can communicate with their patients and provide them with vital information that will help protect their health and save lives,” said Dr. Tashfeen Ekram, Co-founder and Chief Medical Officer at Luma Health. “We are dedicated to helping patients get access to care more quickly, and to working with medical heroes on the front lines to navigate through this global health crisis.”

Clinicians can utilize Luma Health’s Collaboration Hub to coordinate pre-scheduled and on-demand telehealth virtual visits by opening a virtual exam room using Luma Health’s 90-day televisit trial.

To further assist care providers as they begin to become stretched with an increasing number of at-risk patients, Luma Health has compiled a COVID-19 Best Practices for Patient Communication guide (http://www.lumahealth.io/blog/coronavirus-patient-communication-best-practices) to help providers navigate this challenging time.

To learn more about the Luma Health platform, visit http://www.lumahealth.io/platform.

About Luma Health

Luma Health was founded on the idea that healthcare should work better for all patients. Every single point along the care journey should be simple, seamless, and effective, from accessing care to achieving health goals. Luma Health empowers providers to make this a reality through its total patient engagement solution, designed to boost access, streamline patient-provider communications, and help providers grow their business.

Headquartered in San Francisco, Luma Health’s platform is modernizing communication by delivering smarter conversations that drive patient engagement and continuous care, empowering thousands of providers and more than 11 million patients across the United States today. Additional information about the company is available at https://www.lumahealth.io/, https://blog.lumahealth.io/, https://www.linkedin.com/company/lumahealth/, https://www.facebook.com/lumahealth, and https://twitter.com/lumahealthhq.

For media inquiries, please contact:

Alan Tam

Luma Health

(415) 741-3377

alan@lumahealth.io

Share article on social media or email:



Health

Cardean Transistors™ made available to companies and government agencies willing to build handheld Coronavirus detection devices

Leave a comment


We strongly believe that we are holding a critical component to combat the current, but also future, virus attacks. Having said that, we need the support of large companies and government organizations to get this new type of technology in the hands of the masses.


SAN DIEGO (PRWEB)

Cardea Bio, a San Diego based (bio)technology company, has developed a novel technology combining small bits of biology and semiconductor electronics that can be leveraged to develop a rapid coronavirus handheld test device.

Graphene-based Biology-gated Transistors (Cardean Transistors) directly read the molecular signals of active biology using advanced electronics. This proprietary tech breakthrough can rapidly detect and identify disease markers, forever changing the tracking of current and future infectious diseases as it becomes near real-time and handheld.

The groundbreaking detection abilities of this technology have been published in numerous peer-reviewed publications including Nature Biomedical Engineering. Leveraging this innovation, a few partnership organizations have already initiated the work needed to integrate the Cardean Transistor into handheld devices, but more partners are needed.

Cardea is hereby actively reaching out to all large companies and government organizations looking to urgently bring a first-generation handheld Coronavirus detection device to market.

Background information:

Biological systems communicate via signals called molecular interactions. With viruses, those molecular interactions are carried via RNA and protein signals. What the world needs right now is the ability to detect those signals via a handheld tool – in real time – across potentially hundreds of thousands of people simultaneously. These simple yet powerful devices must be connected to the internet for cloud analysis software to enable immediate digital insights to the otherwise invisible virus attack. While semiconductor electronics would appear to be an effective way to detect these signals, silicon is not bio-compatible – meaning it does not function when exposed directly to human and viral samples.

Graphene is a bio-compatible nanomaterial that is an excellent semiconductor like silicon, that can be used in production of electronics transistors. Cardean Transistors, properly configured, can intercept and read out the molecular interactions of biological signaling. Cardea has effectively enabled a new tech-breakthrough, and is ready and willing to partner with companies and government agencies to bring this innovation to the markets in need around the world.

These partnerships will allow for rapid identification and data sharing, leading to a reality of everybody having actionable information available.

Cardea brings significant advantages compared to existing virus testing modalities:

1) Point of Care: Samples do not need to be taken to a lab as the detecting technology fits inside a handheld device using a “lab on a chip” type of technology.

2) Additional Actionable Information: The technology can allow for the testing of multiple molecular signals of interest at the same time. For example, the technology could be used to differentiate if a patient is infected with coronavirus or just the influenza while also testing to see if the individual is already immune to a specific coronavirus strain. Common biological testing approaches, such as PCR and ELISA, are compatible with Cardea technology and in many cases, the long wait-times and extra reagents required of these techniques can be removed by building the assay on a Cardean transistor.

3) A Detection Technology with More Form Factors and Use Cases: The form factors and use cases in which the technology can be integrated are numerous. Other than handheld devices, a version of the technology can be built to e.g. sit in a toilet for ongoing monitoring or as a gate-system in the waiting rooms of hospitals.

The Cardea (bio)technology has been well characterized and was recently recognized in more world-renowned, peer-reviewed journals. Specifically, in June 2019 Cardea’s CRISPR-Chip (a Cardean Transistor version) was the cover story in Nature Biomedical Engineering and became the most read publication in 2019. In an impartial reaction to that paper, Dr. Can Dincer from the Laboratory for Sensors, Department of Microsystems Engineering (IMTEK) at the University of Freiburg noted in Nature News & Views: “The prevalence and spread of antimicrobial resistance worldwide, the (re)emergence of infectious disease outbreaks most recently of Dengue and Zika (…) demand further technology development in nucleic acid testing. (…) CRISPR technology enables simple and easily scalable approaches for building biosensing devices for a wide range of targets including viruses, bacteria, and cancer mutations.”

Cardea’s CEO Michael Heltzen states, “Our Cardean Transistors are incorporated with the natural search power of CRISPR, creating the opportunity to detect the coronavirus faster and more effectively with the differentiated product advantages of being a handheld, fast, precise, and internet-connected device. This enables for the first time the use of cloud computing and other Internet-like applications for life science test results without having to send a sample back to a lab and wait for days before you have the result.”

Heltzen continues, “We strongly believe that we are holding a critical component to combat the current, but also future, virus attacks. Having said that, we need the support of large companies and government organizations to get this new type of technology in the hands of the masses.”

Click here to see a video about how the CRISPR-Chip functions.

Click here to see how Cardea published with the CDC using a “Cardean Transistor” system to detect Zika.

Share article on social media or email:

Industry: Healthcare

Self-Reporting Software Platform To Help First Responders Tackle Coronavirus

Leave a comment


Community Connect enables residents to self-report COVID-19 and high-risk occupant information in minutes – shared directly with Emergency Services for a more prepared response.

With this information at their fingertips, firefighters and EMS personnel will have a much clearer picture of who they are responding to and what their health situation is. — Fire Chief Gary Ludwig, IAFC President and Chairman of the Board.


NEW YORK (PRWEB)

First Due, known to Public Safety agencies across the US for developing next-generation pre-incident planning, mobile response, and community engagement solutions, announced today, in partnership & collaboration with the International Association of Fire Chiefs, a FREE version of their Community Connect platform, in order to help Fire-EMS, Police, Emergency Management, and Healthcare agencies better combat the COVID-19 pandemic.

Community Connect is currently used nationwide, enabling citizens to share critical life safety details of their households and businesses with their respective Public Safety agencies. With the ensuing COVID-19 Health Crisis developing across the United States, First Due has released a COVID-19 focused version of Community Connect, designed to allow residents to self-report their status and take protective actions during the outbreak. Agencies can use this information at the time of response or analyze the data in GIS platforms such as Esri’s ArcGIS.

“This tool will allow fire and EMS agencies the ability to know better where citizens have self-isolated or self-quarantined themselves in their community. With this information at their fingertips, firefighters and EMS personnel will have a much clearer picture of who they are responding to and what their health situation is. The IAFC is pleased to partner with innovative companies and technologies that help provide better, faster, and more capable services for our communities. We are pleased to partner with First Due.” — Fire Chief Gary Ludwig, IAFC President and Chairman of the Board.

Community Connect for COVID-19 offers residents an easy-to-use web portal, available on any device, where they can self-report critical information in line with industry protocol. Within the web portal, residents will be able to share contact, symptom, test, and high-risk related information. Shared information will then be available to First Responders to better prioritize COVID-19 driven care or take proper precautions before entering. Additionally, data collected from residents will be made actionable across GIS applications, such as Esri’s ArcGIS to give Public Safety agencies insight into how the Coronavirus is affecting their community.

“We’ve heard from Public Safety Agencies nationwide how difficult it is to track, manage, and report on current COVID-19 cases in their communities, resulting in First Responder exposures and a lack of situational awareness. Now, more than ever, Emergency Services need this critical information for a more prepared response. For that reason, we ask everyone to take two minutes out of their day to sign up and self-report!” explains Andreas Huber, First Due’s Co-Founder & CEO.

Community Connect for COVID-19 is designed for the sole mission of improving emergency response and community risk area analysis. Data shared via the platform will not be used for any other purpose and is 100% secure featuring bank-level encryption and security standards.

If you are a Public Safety agency and would like to receive First Responder Access to the system, please visit https://www.firstduesizeup.com/communityconnect/covid19 to create your FREE account.

Self-Reporting will be open to the public on Friday the 27th of March at 3:00 PM EST following a formal announcement by First Due.

ABOUT FIRST DUE:

First Due is a public safety software company based in New York City and backed by Teamworthy Ventures, TechNexus, Collate Capital, New York Angels and HBSAANY. First Due’s cloud-based First Responder safety and situational awareness platform re-imagines Pre-Incident Planning, Emergency Response and Community Engagement for public safety agencies nationwide. By automating the aggregation of disparate data sources, and providing powerful planning, mapping and community engagement tools; public safety agencies finally have actionable data on every structure for every call in a format they can consume in seconds.

Departments utilizing First Due such as Seattle, Ft. Lauderdale, Charlotte, and Fort Worth, have the data they need for better decisions before, during and after incidents – leading to more positive outcomes.

To request more information regarding First Due’s products or to get in touch with First Due’s executive team, please visit https://firstduesizeup.com/.

First Due Media Contact:

Ron Kanter

Head of Growth

+1 (516) 874-2258

ron@firstduesizeup.com

ABOUT THE INTERNATIONAL ASSOCIATION OF FIRE CHIEFS:

The IAFC represents the leadership of firefighters and emergency responders worldwide. IAFC members are the world’s leading experts in firefighting, emergency medical services, terrorism response, hazardous materials spills, natural disasters, search and rescue, and public safety legislation. Since 1873, the IAFC has provided a forum for its members to exchange ideas, develop professionally and uncover the latest products and services available to first responders.

IAFC Media Contact:

Jim Philipps

Assistant Director, Strategic Communications

jphilipps@iafc.org

703-537-4829

Share article on social media or email:

Health

American Trust Retirement Adds iJoin to its Goal-Based Retirement Offering

Leave a comment


iJoin Logo

iJoin’s advisor success platform will help us scale while also helping us maintaining the personal touch for which we’re known. ~ Micah DiSalvo


SCOTTSDALE, Ariz. (PRWEB)

American Trust Retirement (ATR) and LDI-MAP LLC (d.b.a. iJoin) are pleased to announce an agreement under which ATR will deploy iJoin as a key component of its branded goal-based retirement plan enrollment experience, advisor success platform and managed account program. iJoin’s technologies are designed to streamline the enrollment process for plan participants while also providing financial advisors with powerful and accessible analytics tools for assessing the health of their plans. ATR, a division of First Mercantile Trust, plans to roll out the new program to all employers on its platform nationally beginning in April.

ATR has been a leader in presenting plan participants a goal-focused approach to their retirement savings path along with the option of a goal-focused, “do-it-for-me” managed account program. Chief Revenue Officer for ATR, Micah DiSalvo explains, “iJoin’s technology aligns with our core philosophy of delivering a superior goal-based enrollment experience that works seamlessly with our advisor-led managed account program. And iJoin’s advisor success platform will help us scale while also helping us maintaining the personal touch for which we’re known.”

Steve McCoy, iJoin’s Chief Executive Officer added, “ATR is well poised to leverage iJoin. Our goal-based methodologies and success-oriented experience for employees, employers, and financial advisors speaks to their business model and differentiators. We’re excited to partner with ATR to help produce better long-term retirement outcomes.”

ATR’s goal-oriented enrollment experience powered by iJoin shows each participant their personal retirement funding needs and encourages them to take the necessary steps to reach their goals. The program sends participants a quarterly “Personal Retirement Picture” that offers a snapshot of goal completion and makes recommendations to improve outcomes.

With the new program, advisors can easily view information across all plans, compare plan performance against benchmarks, and drill-down into individual plan or participant-level data to pinpoint opportunities for improvement. The integrated iJoin technology helps advisors encourage participants to take action through sophisticated, easy-to-use targeted and context-specific email campaigns built into the platform.

About American Trust Retirement

American Trust Retirement is a division of First Mercantile Trust, a non-depository trust company domiciled in Tennessee. It is part of EdgeCo Holdings which, along with its sister companies, is a leading provider of best-in-class technology-enabled solutions for financial professionals and their clients. Collectively the portfolio of companies provides a suite of technology and support services including full-service retirement plan administration, brokerage, advisory, and trust and custody to a diverse national client base of financial intermediaries. This client base includes registered representatives, investment advisors, and other financial organizations including retirement plan record-keepers, TPAs, bank trust departments, broker dealers, and insurance companies. The firm services approximately $120 billion in client assets under custody or administration and more than 10,000 financial advisors and 500 financial institutions. Visit americantrustretirement.com.

About LDI-MAP, LLC (dba iJoin)

The iJoin team is committed to personalizing retirement success™ and making it easy for millions of savers to get on a path to better retirement outcomes. As a financial technology partner to the retirement plan industry, iJoin’s goal-based retirement plan enrollment experience helps people immediately understand their retirement funding need and encourages action to get on track. iJoin supports financial advisors and recordkeepers with actionable data and tools to more effectively engage both employers and their employees. LDI-MAP (d.b.a. iJoin) is a registered investment advisor with the State of Arizona – 14646 N. Kierland Boulevard, Suite 125 Scottsdale, AZ 85254. Learn more at ijoinsuccess.com.

Share article on social media or email:

Industry: Healthcare

The American Association of Naturopathic Physicians Urges Authorities to Include and Use Licensed Naturopathic Doctors in Plans to Combat the Novel Coronavirus Pandemic

Leave a comment


AANP logo

Serving in primary and specialty care, NDs are ready, willing, and able to support other medical professionals in changing the trajectory of this public health crisis.


WASHINGTON (PRWEB)

The American Association of Naturopathic Physicians (AANP), representing 8,000 licensed naturopathic doctors (NDs) in the United States, encourages all government officials coordinating the national response to the 2019 Novel Coronavirus Pandemic (COVID-19) to to utilize all licensed healthcare professionals in this health emergency, including NDs. Licensed NDs work collaboratively across all forms of medicine, and in regulated states are already integrated into health systems. Serving in primary and specialty care, NDs are ready, willing, and able to support other medical professionals in changing the trajectory of this public health crisis.

Health literacy and patient education are central components of the naturopathic doctor’s approach to patient-centered care. Many current public health practices and lifestyle recommendations are foundational principles of naturopathic medicine and inform our approach to support public health efforts through this current pandemic. We stand in solidarity with our colleagues at the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and State and Local governments in promoting essential public health measures to reduce the burden on U.S. and global healthcare systems.

We call on Federal, State and Local authorities to engage naturopathic doctors in emergency measures to supplement the healthcare workforce during this crisis, recognizing:

  • NDs are trained comparably to conventional doctors to diagnose and triage according to presenting symptoms, refer to the appropriate level of care, and support patients during at-home symptom management.

  • NDs practice patient-centered medicine and tailor personalized care plans. In addition to all public health recommendations, NDs employ a toolkit of treatment approaches that can be used to support the body’s inherent immune capacity to prevent viral infections, address viral infections directly, ease symptoms in those infected, and support recovery during post-infection care.

Further, we recommend the following actions be taken to empower licensed naturopathic doctors to promote the health and safety of those at highest risk:

  • Increase access to care: Licensed NDs can serve in states that have declared states of emergency and are calling for volunteer healthcare practitioners to prevent their healthcare systems from becoming overwhelmed.

  • Increase access to Telemedicine services: We call on insurance providers who currently cover the services of licensed NDs to cover telehealth services provided by NDs, following the recent Telehealth guidelines issued by CMS. This will allow NDs to continue treating patients with chronic diseases or comorbidities that make them more susceptible to SARS-CoV-2, and will allow patients to stay safely at home.

  • Expedite research on novel agents: Many agents in the naturopathic medicine toolkit have been shown to have a pharmacological effect on related viruses. Naturopathic doctors are the only licensed health care providers trained in the science and clinical use of these agents. We encourage the rapid exploration and study of novel agents that may serve to slow the progression of this particular pandemic, inclusive of relevant research coming out of countries with strong histories of using traditional medicines safely and effectively.

AANP President, Robert Kachko, ND, LAc, stated, “Naturopathic doctors are well-equipped to diagnose and refer to the most appropriate level of care based on clinical presentation and diagnostic staging, supporting continued access to our limited local healthcare resources for our most vulnerable populations. In particular, we encourage those individuals who test positive to the SARS-CoV-2 virus but are instructed by healthcare authorities to self-quarantine at home to receive personalized care from naturopathic doctors via telemedicine.”

The American Association of Naturopathic Physicians and its affiliated organizations will remain a resource to our colleagues in health and medicine, working to limit this pandemic and ensure the continued health and safety of our nation.

About the American Association of Naturopathic Physicians

The American Association of Naturopathic Physicians (AANP) is the professional association that represents licensed naturopathic physicians. AANP strives to make naturopathic medicine available to every American, and to increase recognition of naturopathic physicians as the identified authorities on natural medicine. Learn more at http://www.naturopathic.org.

Share article on social media or email:

Health: Psychology

Drug, Anti-drug Antibody Inform Personalized Decisions in Gastroenterology & Rheumatology, Upcoming Webinar Hosted by Xtalks

Leave a comment


Xtalks Life Science Webinars

Biologic drugs are prime candidates for therapeutic drug monitoring (TDM) because they are very expensive, relatively few, subject to wide pharmacokinetic variability, and unfortunately, significant primary and secondary failure rates.


TORONTO (PRWEB)

Biologic drug therapies have proven to be precious in the treatment of inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and other immune-mediated diseases — due to not only their high financial cost but also their finite number and variable longevity. Approved biologic drugs to treat inflammatory bowel disease and/or rheumatoid arthritis include monoclonal antibodies against integrin (vedolizumab and natalizumab), interleukin 12 and 23 (ustekinumab), and TNF (infliximab, adalimumab, golimumab, certolizumab, etanercept and the biosimilars, infliximab-abda and infliximab-dyyb).

Biologic drugs are prime candidates for therapeutic drug monitoring (TDM) because they are very expensive, relatively few, subject to wide pharmacokinetic variability, and unfortunately, significant primary and secondary failure rates. As these biologic drugs comprise a staggering healthcare cost (Humira®, Remicade®, and Stelara® gross $31 billion in 2018), we consider how the use of these precious medications might be optimized by biologic therapeutic drug monitoring.

The clinical value of therapeutic drug monitoring is predicated on the existence of a parallel relationship between measurements of drug (or antibody) in patient sample and outcomes. In the case of biologic drugs, therapeutic drug monitoring also implies the detection and quantitation of anti-drug antibodies. The anti-drug antibody measurement together with the concomitant free drug level provides critical pharmacokinetic and immunogenic assessment that cannot be otherwise be ascertained clinically.

Here, we discuss the application of biologic therapeutic drug monitoring to inform and expedite personalized clinical decision-making, such as:


  • Patient-specific dose titrating to target or maximally beneficial concentrations

  • Diagnosing of immunogenicity

  • Determining co-therapies and biologic switching

  • Improving longevity of therapy

  • Reducing drug waste and overall healthcare costs

  • Supporting proactive management

Furthermore, recent data show that some patients with secondary failure due to immunogenicity may recapture clinical response as a result of treating away existing anti- drug antibodies.

The live session takes place on Wednesday, April 8, 2020 at 1pm EDT with guest speakers Dr. Jane Yang, Director of Medical Science at Esoterix Laboratory Services and Dr. Kelly Chun, Vice President and Scientific Director of Esoterix/Endocrine Sciences (Esoterix Laboratory Services and Esoterix/Endocrine Sciences are part of the LabCorp Specialty Testing Group).

For more information or to register for this event, visit Biologic Therapeutic Drug Monitoring: Drug, Anti-drug Antibody Inform Personalized Decisions in Gastroenterology & Rheumatology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

American Advance Practice Network Launches CareSpan USA, Inc. COVID-19 Screening-and-Response Program

Leave a comment


News Image


WATERTOWN, S.D. (PRWEB)

American Advanced Practice Network (American-APN), a multi-state network of nurse practitioners using the CareSpan digital platform for care delivery, are the first clinicians using the CareSpan COVID-19 Screening-and-Response (S&R) Program.

CareSpan USA, an integrated digital care platform for healthcare delivery, developed and launched a screening-and-response program for individuals concerned that they may have contracted the new coronavirus and COVID-19. The CareSpan COVID-19 Screening-and-Response (S&R) Program was designed with input from physicians, nurse practitioners and doctors-of-public-health to enable risk assessment and counseling of anyone concerned about the new coronavirus disease, regardless of location.

“The current COVID-19 pandemic presents a challenge to state and local governments and the medical community at large to provide a safe, easily accessible method through which concerned individuals may take a first step, to be screened to determine if they are currently appropriate for COVID-19 testing,” said Melissa Magstadt, President American-APN MS, MBA, APRN. “Health departments, emergency rooms and doctors’ offices can be relieved of the burden of evaluating large numbers of anxious patients for indications for testing and self-care instructions. Our current program initiated in South Dakota, Iowa and Colorado. We plan on extending the program to Washington and Florida shortly,” Magstadt added.

The CareSpan COVID-19 S&R Program puts each patient in video contact with a qualified health professional, establishes a record for each person, uses data coupled with direct observation to assess each person’s risk and susceptibility profile, then guides that person to testing and care as indicated. It also establishes a follow-up opportunity for continuity-of-care to all screened persons should that be necessary.

“The current Coronavirus crisis understandably generates fear and concern among individuals and families. The CareSpan COVID-19 S&R program provides the potential for an early and orderly assessment of symptoms and recommended responses for all Americans and is meant to augment and support control and containment measures being implemented by public and private sector leadership in the U.S., ” noted Rembert De Vila, CareSpan’s Chief Executive Officer. De Villa concluded, “CareSpan is committed to contribute to this global COVID-19 fight.”

Patient information: http://www.americanapn.com/patientscreening

Healthcare professional and health systems information: http://www.americanapn.com/healthsystems

About American Advanced Practice Network American-APN is the first professional “group practice without walls” that brings highly qualified nurse practitioners to those in need of health care under a collaborative care system that uses integrated digital care technologies. American-APN owned and operated exclusively by its nurse practitioner membership http://www.americanapn.com.

About CareSpan USA

CareSpan USA is a subsidiary of CareSpan Holdings, Inc. CareSpan USA designs, develops and deploys telemedicine, telehealth and integrated digital care technologies for use by the medical and healthcare professionals in serving patients worldwide.: http://www.carespanhealth.com.

Share article on social media or email:

Industry: Healthcare

Early Registration Extended for 2020 Health Care Quality and Management Certification (HCQM®) Exam

Leave a comment


Board Certification

CHCQM Board Certified

HCQM Certification is the only health care quality and management certification administered through the National Board of Medical Examiners® (NBME®).


NEW PORT RICHEY, Fla. (PRWEB)

(ABQAURP) 24 March 2020 – The importance of health care quality and patient safety is paramount in providing medical care in today’s environment. It is essential that health care providers and administrators demonstrate their expertise and commitment to health care quality and safety. According to ABQAURP Chairman of the Board, Dr. Arthur Broder, “Employers adopting HCQM Certification and education for their medical staff allows them to say to outside interests that they have the highest possible standards for their medical team by certifying them through an independent, non-profit organization (ABQAURP) that is dedicated to ensuring health care quality and management.”

In addition to concerns about patient safety, inappropriate services, and unnecessary readmissions, the rising costs of health care and its impact on families and business all solidify the need for Health Care Quality and Management (HCQM) Certification.

Realizing what a hectic time it is for health care professionals around the world, ABQAURP strives to make certification accessible, therefore the early registration deadline and the extra savings promotion have been extended through April 22, 2020, to allow medical professionals time to concentrate on what’s important now – taking care of family, patients, and staff. ABQAURP humbly thanks you for your tireless efforts during this unprecedented time.

Validate your expertise with a certification that demonstrates knowledge and commitment to safety, health care quality, and effective care. HCQM Certification is a definitive benchmark of achievement signifying a higher level of proficiency; and is the only health care quality and management certification administered through the National Board of Medical Examiners® (NBME®).

ABQAURP continues to deliver the highest quality certification process, bringing examinees a certification based on definable standards upheld by knowledgeable experts.

Health care leaders can enhance their HCQM credential with additional sub-specialty certifications in the following categories:

-Case Management

-Managed Care

-Patient Safety / Risk Management

-Physician Advisor (Physicians Only)

-Transitions of Care

-Workers’ Compensation

The HCQM Examination and Physician Advisor Sub-Specialty are endorsed by the American College of Physician Advisors. HCQM Certification and the physician advisor sub-specialty align with ACPA’s mission to promote and expand the prominent role of the Physician Advisor in today’s rapidly changing health care environment through education, certification, mentorship, and collaboration; as well as ABQAURP’s mission to improve the overall quality of health care provided to the public.

Dr. Charles Locke, President of the American College of Physician Advisors (ACPA), Senior Physician Advisor for The Johns Hopkins Hospital and ABQAURP Diplomate states, “I found the HCQM Certification with Physician Advisor sub-specialty to be invaluable in my development as a physician advisor. The certification process helped broaden and solidify my knowledge in so many areas including health care quality metrics, payer models, and the role of case management.”

Prepare now for the 2020 HCQM Examination! Now accepting applications for the HCQM Test Window that will be open from August 15 through October 15, 2020. The extended Early Registration Discount is now valid through April 22, 2020; register now to save $50 off the HCQM Exam Fee.

As an additional incentive, save up to $150 when using Promo Code: HCQM20PR to save $75 on the Core Body of Knowledge online course and $75 on the HCQM Exam Fee (when used in conjunction with the $50 early registration discount currently in place). Exam candidates do not need to purchase at the same time, but must register for both no later than April 22nd to maximize savings. Promotion cannot be used in conjunction with other offers.

Visit the ABQAURP website at: http://www.abqaurp.org/Certification or call (800) 998-6030 to learn how HCQM Certification can validate your experience and set you apart from the rest!

“National Board of Medical Examiners®” and “NBME®” are registered trademarks of the National Board of Medical Examiners.

About ABQAURP

Celebrating over 40 years of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide. Learn more at: http://www.abqaurp.org.

About the ABQAURP and ACPA Alliance

ABQAURP and ACPA formed the alliance to offer the first Physician Advisor sub-specialty for the HCQM certification. HCQM Certification and the physician advisor sub-specialty align with ACPA’s mission to promote and expand the prominent role of the Physician Advisor in today’s rapidly changing health care environment through education, certification, mentorship, and collaboration; as well as ABQAURP’s mission to improve the overall quality of health care provided to the public.

Share article on social media or email:

Health

Lightning Labels client Vapergate rolls out Rocky Mountain Distribution CBD products

Leave a comment


Vapergate rolls out Rocky Mountain Distribution CBD products

RMD being well prepared and planning ahead, printing of their new product labels has gone smoothly. In essence, it’s been business as usual, an unusual attribute when an entire new product line launches.


DENVER (PRWEB)

Capitalizing on a tradition of product safety and quality control in the vape industry, Vapergate has launched a series of top-quality CBD products featuring independent testing and public sharing of results through newly-formed Rocky Mountain Distribution (RMD).

CBD products including flower, pre-roll joints, isolate powder, full-spectrum powder including THC, tinctures, bath bombs, and pet treats are being offered through three established brands—Groove CBD, Purple Sky CBD and Fox Stone CBD, according to RMD spokesperson Ryan McKibben. New branding, featured on RMD’s custom labels produced by Lightning Labels and carried through the firm’s complete marketing campaign, will help set RMD apart in the CBD marketplace.

Notes McKibben, “For a few years we had Vapergate clients asking us if we were getting into the CBD industry. The two owners and I all had personal interest in CBD and we decided to test the waters and formed Rocky Mountain Distro.”

McKibben adds, “The thought behind it was to have a clear point of purchase for several brands, not just our own ventures, where we would independently test the products we were selling and make lab reports public, so shops don’t have to rely strictly on the manufacturer’s word or lab reports for the quality of their products. So if we decide to bring a brand in to distribute to our customer base, not only will we have the labs for the company but also our own labs, run from product pulled randomly from their product inventory in our warehouse. There is a lot of distrust in the CBD industry, and we want to fix that.”

McKibben points out that CBD, as with vape, has attracted “everybody” to the marketplace, resulting in quality control challenges. Further, notes McKibben, “Anyone can do it. Eighty-percent of the products on the market are white label items from a few large sources, so the products out there are all the same. We decided when we got into this industry that we weren’t going to white label anything. We’re leveraging six-plus years of manufacturing, sales and branding experience to bring better products to market instead of just throwing our logo on the same old products you see all over the place. If we don’t feel like we can do it better than others, we aren’t going to do it at all.”

“Doing it better” also applies to RMD’s branding, according to Ryan Tennant, account manager of Lightning Labels, the custom label printer for both Vapergate and RMD. “Longevity and experience in the vape industry provided the perfect platform for launching CBD,” notes Tennant. “They developed compelling, yet simple branding for the new company that provided clear separation from the vape industry. Because of RMD being well prepared and planning ahead, printing of their new product labels has gone smoothly. In essence, it’s been business as usual, an unusual attribute when an entire new product line launches.”

Where

In addition to a soft rollout of existing Lakewood, Denver and Broomfield Vapergate retail locations, select retailers nationwide also are picking up the products. RMD is planning to open a retail CBD location in Aurora as well. Online ordering can be handled through rockymountaindistro.com.

Why Rocky Mountain Distribution

McKibben emphasizes that superior, fully-tested products and reliable, efficient fulfillment give RMD a competitive edge.

In the testing arena, McKibben points out that independent, multi-layer testing means that customers and retailers can buy with confidence. In addition to manufacturer testing, RMD will test all products before green lighting their availability.

Unlike many CBD products that can take 1-2 weeks turnaround time on orders, RMD has top-of-the-line facilities in place to ensure same or next-day shipping. McKibben laments, “There is a lack of professionalism from many CBD companies out there. We’ve optimized our operations over the course of five years in business, so we can provide consistent and predictable results.”

About Lightning Labels:

Lightning Labels uses state-of-the-art printing technology to provide affordable, full-color custom labels and custom stickers of all shapes and sizes. From small orders for individuals to the bulk needs of big businesses, Lightning Labels is equipped to handle and fulfill custom label and sticker projects of all types. Best of all, like the name implies, Lightning Labels provides a quick turnaround for every customer’s labeling needs. Uses for Lightning Labels’ custom product labels and custom stickers include food packaging and organic food labels, wine and beverage labels, bath and body labels, and nutraceutical products, such as vitamins, essentials oils, and herbal remedies, as well as event stickers, adhesive window stickers and more. Lightning Labels strongly supports the development of environmentally friendly printing materials and carries Biostone, a green label material made from stone paper is water resistant and inherently strong and durable. While operating as a high-tech printer, Lightning Labels prides itself on its personalized customer service. Lightning Labels provides one stop shopping for all of your custom label needs. For more information and to place orders online, visit LightningLabels.com. For the latest in packaging news and labeling promotional offers, find Lightning Labels on Twitter (@LightningLabels), Facebook, Pinterest, and LinkedIn.

Share article on social media or email: